Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CORT | Corcept Therapeutics | $34.68 | -$35.52 | -50.59% | 5.7M | $7.4B | $34.18$117.33 |
| SMX | Smx (Security Matters) Public | $31.60 | -$19.85 | -38.58% | 10.6K | $54M | $3.12$42,793.50 |
| RAIN | Rain Enhancement Technologies Holdco | $6.46 | -$1.67 | -20.54% | 44.1K | $67M | $1.75$10.84 |
| WOK | Work Medical Technology Group Ltd | $2.47 | -$0.47 | -15.99% | 221.5K | $26K | $2.43$60,000.00 |
| EKSO | Ekso Bionics | $9.05 | -$1.53 | -14.47% | 2.1M | $36M | $2.73$14.97 |
| GLSI | Greenwich LifeSciences | $19.15 | -$2.77 | -12.64% | 248K | $304M | $7.78$30.82 |
| CDIO | Cardio Diagnostics | $2.84 | -$0.34 | -10.69% | 18.3K | $5.8M | $2.42$30.60 |
| JYD | Jayud Global Logistics | $4.72 | -$0.28 | -5.52% | 1.4K | $14M | $2.71$400.00 |
Related Articles
Featured Article
3 Reasons Why Corcept Therapeutics Is a Better Buy Than Shiba Inu Coin
Alex Carchidi|Feb 23, 2022
Making medicines is a more reliable path to share price appreciation than memes.
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
3 Healthcare Stocks That Could Be Millionaire-Makers
James Halley|Mar 24, 2021
With solid revenue growth, these stocks have the potential to more than triple over the next few years.
Advertisement
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
2 Monster Stocks in the Making
Alex Carchidi|Sep 24, 2020
These two biotechs have the potential to become giants within their domains.
Should You Climb on Board the Corcept Therapeutics Train?
James Halley|May 12, 2020
This biotech company has seen huge growth over the past five years.
3 High-Growth Stocks That Could Soar
Brian Feroldi, Anders Bylund, and Maxx Chatsko|Aug 20, 2018
Find out why two tech stocks and a small-cap biotech look like compelling investment opportunities right now.
3 Highest Growth Stocks in the Market Today
Brian Feroldi|Dec 4, 2017
Profit growth doesn't get any faster than this.
3 Top Stocks Under $5
Maxx Chatsko|Dec 4, 2017
Investors may want to put Idera Pharmaceuticals, Yamana Gold, and Ekso Bionics on their watchlists.
